Gyros Protein Technologies

Determination of physical viral vector titer in process development & QC for cell & gene therapy

This article emphasizes the importance of efficient analytics in the production of viral vectors for therapies, focusing on critical quality attributes such as vector titers and full-to-empty capsid ratios. It reviews analytical methods that support process development and QC, highlighting the role of the Gyrolab in overcoming the limitations of traditional methods through miniaturized, automated immunoassays.

CGT insight article

Fill in the form to download the article